


<!DOCTYPE html>
<html lang="en">
<head><script src="//archive.org/includes/analytics.js?v=cf34f82" type="text/javascript"></script>
<script type="text/javascript">window.addEventListener('DOMContentLoaded',function(){var v=archive_analytics.values;v.service='wb';v.server_name='wwwb-app17.us.archive.org';v.server_ms=323;archive_analytics.send_pageview({});});</script><script type="text/javascript" src="/static/js/wbhack.js?v=1531166943.0" charset="utf-8"></script>

<script type="text/javascript">
__wbhack.init('https://web.archive.org/web');
</script>
<link rel="stylesheet" type="text/css" href="/static/css/banner-styles.css?v=1531166943.0" />
<link rel="stylesheet" type="text/css" href="/static/css/iconochive.css?v=1531166943.0" />

<!-- End Wayback Rewrite JS Include -->  

        <title>Myelodysplastic syndromes (MDS): percentage of higher-risk MDS patients receiving azacitidine or decitabine. | National Quality Measures Clearinghouse</title>

    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width">
    <link rel="icon" href="/web/20180621173252im_/https://www.qualitymeasures.ahrq.gov/UI/images/favicon-NQMC.ico">
    <link rel="apple-touch-icon" sizes="180x180" href="/web/20180621173252im_/https://www.qualitymeasures.ahrq.gov/UI/images/apple-touch-icon-NQMC.png">
    <link rel="icon" type="image/png" href="/web/20180621173252im_/https://www.qualitymeasures.ahrq.gov/UI/images/favicon-NQMC-32x32.png" sizes="32x32">
    <link rel="icon" type="image/png" href="/web/20180621173252im_/https://www.qualitymeasures.ahrq.gov/UI/images/favicon-NQMC-16x16.png" sizes="16x16">
    <link rel="manifest" href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/UI/images/manifest-NQMC.json">
    <link rel="mask-icon" href="/web/20180621173252im_/https://www.qualitymeasures.ahrq.gov/UI/images/safari-pinned-tab-NQMC.svg" color="#222c66">
    <meta name="theme-color" content="#ffffff">
    
<link href="/web/20180621173252cs_/https://www.qualitymeasures.ahrq.gov/cassette.axd/stylesheet/50802fec44b49e78c77b55e1df8361e3dbe9a339/NQMCSiteCSS" type="text/css" rel="stylesheet"/>
<!--[if lt IE 9]>
<link href="/cassette.axd/stylesheet/2188ac5b8507764bb4079068f7a3c8d7ccfba0e7/ieCSS" type="text/css" rel="stylesheet"/>
<![endif]-->



    <script async type="text/javascript" id="_fed_an_ua_tag" src="https://web.archive.org/web/20180621173252js_/https://dap.digitalgov.gov/Universal­-Federated-­Analytics-­Min.js?agency=HHS&amp;subagency=AHRQ"></script>
    </head>
<body class="no-js content-page">
<a href="#main-content" id="skip-nav">Skip to main content</a>
<!--https://developers.google.com/tag-manager/devguide#multidomain  ECH-1199-->
    
    <!-- Google Tag Manager -->
    <noscript>
        <iframe src="//web.archive.org/web/20180621173252if_/https://www.googletagmanager.com/ns.html?id=GTM-W4NX5V" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180621173252/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-W4NX5V');</script>

    <noscript>
        <iframe src="//web.archive.org/web/20180621173252if_/https://www.googletagmanager.com/ns.html?id=GTM-KXQCDQ" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180621173252/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-KXQCDQ');</script>
    <!-- End Google Tag Manager -->


    <!-- AHRQ HEADER -->
<div id="ahrq-header">

	<p class="hhs-links">
		<a href="https://web.archive.org/web/20180621173252/http://www.hhs.gov/" target="_blank" class="logo-hhs"><span class="logomark"></span>U.S.&nbsp;Department of&nbsp;Health&nbsp;and Human&nbsp;Services</a>
		<a href="https://web.archive.org/web/20180621173252/http://www.hhs.gov/" target="_blank" class="external-link"><strong>HHS.gov</strong></a>
	</p><!-- /.hhs-links -->
	<p class="ahrq-links">
		<a href="https://web.archive.org/web/20180621173252/http://www.ahrq.gov/" target="_blank" class="logo-ahrq">Agency for Healthcare Research and Quality: Advancing Excellence in Health Care</a>
		<a href="https://web.archive.org/web/20180621173252/http://www.ahrq.gov/" target="_blank" class="external-link"><strong>AHRQ.gov</strong></a>
	</p><!-- /.ahrq-links -->

</div><!-- /#ahrq-header -->

	<!-- HEADER -->
	<div class="header" id="header">
		<div class="masthead">

			<ul class="header-actions">
				<li><a href="#header-search" class="search-action"><span class="label">Search</span></a></li>
				<li><a href="#header-account" class="account-action"><span class="label">Account</span></a></li>
				<li><a href="#main-nav" class="menu-action"><span class="label">Menu</span></a></li>
			</ul><!-- /.header-actions -->
				
				<a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/" class="header-logo NQMC">
				    <picture>
				        <source media="(min-width: 960px)" srcset="/web/20180621173252im_/https://www.qualitymeasures.ahrq.gov/UI/images/logo_NQMC_header.png">
				        <source srcset="/web/20180621173252im_/https://www.qualitymeasures.ahrq.gov/UI/images/logo_NQMC_header_m.png">
				        <img src="/web/20180621173252im_/https://www.qualitymeasures.ahrq.gov/UI/images/logo_NQMC_header.png" alt="National Quality Measures Clearinghouse">
				    </picture>
				</a>
<form action="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/search" class="header-search header-action" enctype="multipart/form-data" id="header-search" method="get">					<p class="search-bar">
						<label for="q"><span class="screen-reader-text">Search</span>
							<input id="q" type="text" title="Search Input" name="q" class="search-input" placeholder="Search">
						</label>
						<input id="masthead-search-button" type="submit" title="Search Submit" class="search-submit" value="Search">
					</p>
					<p class="search-tips">
						<a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/help-and-about/search-browse/search-tips">Search Tips</a>
					</p>
</form>				<div class="header-account header-action" id="header-account">
				<a id="login-button" class="signin" href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/accounts/signinlanding" aria-role="tab" aria-controls="login-panel" aria-selected="false">Log into My NQMC</a>
<div id="login-panel" class="login dropdown" aria-role="tab-panel" aria-labeledby="login-button" aria-hidden="true">
    
            <div class="sign-in">
            <form id="sign-in-form" action="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/Accounts/LoginSubmit" method="post">
                <h3>Sign In</h3>
                <div class="errormessages"></div>
                <p class="invalid-user-cred message-block" style="display: none;"></p>
                <p>
                    <label for="sign-in-username">Username or Email <span class="required">*</span></label>
                    <input type="text" id="sign-in-username" class="input-text" name="email" required>
                   
                </p>
                <p>
                    <label for="sign-in-userpwd">Password <span class="required">*</span></label>
                    <input type="password" id="sign-in-userpwd" class="input-text" name="password" required>
                  
                </p>
                <p class="form-link"><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/accounts/forgotpassword">Forgot Password?</a></p>
                <p><label for="remember-me"><input type="checkbox" name="remember-me" id="remember-me">Remember Me</label></p>
                <input id="account-sign-in" type="submit" value="Sign In"/>
            </form>
            <p>
                <label for="sign-up-btn">Don't have an account?</label>
                <a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/accounts/login" class="sign-up-btn" id="sign-up-btn">Create New Account</a>
            </p>
        </div><!--/.sign-in-->
</div><!-- /.login -->
				</div><!-- /.header-account -->
		</div><!-- /.masthead -->

		<div class="main-nav header-action" id="main-nav">
		    <ul class="level-1">
		        <li class=""><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/">Home</a></li>
		        <li class=""><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/new-this-week/index">New This Week</a></li>
		        <li>
                    <a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/summaries/browse" class="parent-link">Measure Summaries</a>		            <ul class="level-2 dropdown">
		                    <li class=""><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/browse/domain">By Measure Domain</a></li>
                            <li class=""><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/browse/setting">By Measurement Setting</a></li>
		                <li class=""><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/browse/organization">By Organization</a></li>
		                <li class=""><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/browse/mesh-tag">By MeSH Tag</a></li>
		                <li class=""><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/summaries/in-progress">In Progress</a></li>
		                <li class=""><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/summaries/archive">Archive</a></li>

		                <li class=""><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/search?f_DocType=302&amp;fLockTerm=Measure Summaries">All Summaries</a></li>
		            </ul>
		        </li>
		        <li class=""><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/expert">Expert Commentaries</a></li>
		        <li class=""><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/matrix">Matrix Tool</a></li>
		        <li class="">
                    <a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/summaries/submit">Submit Measures</a>		        </li>
                <li class=""><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/help-and-about">Help &amp;&nbsp;About</a></li>		      
		    </ul>
		</div><!-- /.main-nav -->
</div><!-- /.header -->

    <br/><div class="content"><div class="fundingNotice2"><b>The AHRQ National Quality Measures Clearinghouse (NQMC, qualitymeasures.ahrq.gov) Web site will not be available after July 16, 2018</b> because federal funding <br/>through AHRQ will no longer be available to support the NQMC as of that date. For additional information, read our <a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/home/announcements">full announcement</a>.</div></div>

	<!-- CONTENT -->
	<main id="main-content" tabindex="-1">
		

<div class="main">

		<div class="aside-container">

	<div class="content">

    <!-- CONTENT HEADER -->
    <div class="content-header">
        <ul class="content-header-meta">
            <li class="prefix-icon guideline">Measure Summary</li>
            <li>NQMC:011022</li>
            <li>Feb 2017
            </li>            
                                </ul>
        <div>
                <h1>Myelodysplastic syndromes (MDS): percentage of higher-risk MDS patients receiving azacitidine or decitabine.</h1>
        </div>
    </div>
    <!-- /.content-header-meta -->

        <!-- CONTENT TABS -->
        <ul class="content-tabs">
            <li><a href="#developer-tab" class="developer is-active"><span class="label">Developer</span></a></li>
            <li><a href="#source-tab" class="source"><span class="label">Source</span></a></li>
            <li><a href="#status-tab" class="status"><span class="label">Status</span></a></li>
            <li><a href="#classification-tab" class="classification"><span class="label">Classification</span></a></li>
        </ul>
        <div id="developer-tab" class="is-active content-tab-panel">
                <ul class="developer-list">
        <li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/search?f_Developer_String=American%20Society%20of%20Hematology&amp;fLockTerm=American%2BSociety%2Bof%2BHematology">American Society of Hematology</a></li>
                        <li>   
                                <a id="1942" href="#" data-alert="SignInLanding" data-alert-type="organization" class="get-alerts get-org-alerts">Get Alerts</a>
                        </li>
                </ul>
        </div>
    <!-- /.content-tab-panel -->
    <div id="source-tab" class="content-tab-panel">
<table><tr><td>American Society of Hematology (ASH). Myelodysplastic syndromes (MDS) measure set: measure specifications. Washington (DC): American Society of Hematology (ASH); 2017 Feb. 14 p. </td></tr></table>            </div>
    <!-- /.content-tab-panel -->
    <div id="status-tab" class="content-tab-panel">
            <p><div class="content_para"><p>This is the current release of the measure.</p>
<p>This measure updates a previous version: American Society of Hematology (ASH). Myelodysplastic syndromes (MDS) measure set: measure specifications. Washington (DC): American Society of Hematology (ASH); 2015 Dec. 16 p.</p></div></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="classification-tab" class="content-tab-panel">


        
            <h4>Measure Hierarchy</h4>
<a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/search?f_Collection_Hierarchy=objid49210&amp;fLockTerm=Myelodysplastic%2BSyndromes%2BMeasure%2BSet">Myelodysplastic Syndromes Measure Set</a>                    <h4>Age Group</h4>
            <ul>
                        <li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/search?f_Target_Population_Age=Adult%3A%2080%20years%20old%20and%20older&amp;fLockTerm=Adult%253a%2B80%2Byears%2Bold%2Band%2Bolder">Adult: 80 years old and older</a></li>                                              
                        <li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/search?f_Target_Population_Age=Adult%3A%2065-79%20years%20old&amp;fLockTerm=Adult%253a%2B65-79%2Byears%2Bold">Adult: 65-79 years old</a></li>                                              
                        <li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/search?f_Target_Population_Age=Adult%3A%2045-64%20years%20old&amp;fLockTerm=Adult%253a%2B45-64%2Byears%2Bold">Adult: 45-64 years old</a></li>                                              
                        <li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/search?f_Target_Population_Age=Adult%3A%2019-44%20years%20old&amp;fLockTerm=Adult%253a%2B19-44%2Byears%2Bold">Adult: 19-44 years old</a></li>                                              
            </ul>
                    <h4>UMLS Concepts <a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/help-and-about/search-browse/umls-concepts" class="what-is">(what is this?)</a></h4>
                <div class="field">
                    <h5 class="field-label">ICD9CM</h5>
                    <div class="field-content">
<a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/search?f_ICD9CM_CUI=C3463824&amp;fLockTerm=Myelodysplastic+syndrome%2c+unspecified">Myelodysplastic syndrome, unspecified</a>
 (238.75)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MSH</h5>
                    <div class="field-content">
<a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/search?f_MSH_CUI=C0004475&amp;fLockTerm=Azacitidine">Azacitidine</a>
, <a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/search?f_MSH_CUI=C3463824&amp;fLockTerm=Myelodysplastic+Syndromes">Myelodysplastic Syndromes</a>
, <a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/search?f_MSH_CUI=C0033325&amp;fLockTerm=Prognosis">Prognosis</a>
, <a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/search?f_MSH_CUI=C0036859&amp;fLockTerm=Severity+of+Illness+Index">Severity of Illness Index</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MTH</h5>
                    <div class="field-content">
<a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/search?f_MTH_CUI=C0004475&amp;fLockTerm=Azacitidine">Azacitidine</a>
, <a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/search?f_MTH_CUI=C0049065&amp;fLockTerm=decitabine">decitabine</a>
, <a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/search?f_MTH_CUI=C0033325&amp;fLockTerm=Forecast+of+outcome">Forecast of outcome</a>
, <a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/search?f_MTH_CUI=C2827405&amp;fLockTerm=International+Prognostic+Scoring+System+(IPSS)+for+Myelodysplastic+Syndromes">International Prognostic Scoring System (IPSS) for Myelodysplastic Syndromes</a>
, <a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/search?f_MTH_CUI=C3463824&amp;fLockTerm=MYELODYSPLASTIC+SYNDROME">MYELODYSPLASTIC SYNDROME</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">PDQ</h5>
                    <div class="field-content">
<a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/search?f_PDQ_CUI=C0004475&amp;fLockTerm=azacitidine">azacitidine</a>
, <a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/search?f_PDQ_CUI=C0049065&amp;fLockTerm=decitabine">decitabine</a>
, <a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/search?f_PDQ_CUI=C3463824&amp;fLockTerm=myelodysplastic+syndromes">myelodysplastic syndromes</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">SNOMEDCT_US</h5>
                    <div class="field-content">
<a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C0004475&amp;fLockTerm=Azacitidine">Azacitidine</a>
 (412328000), <a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C0004475&amp;fLockTerm=Azacitidine">Azacitidine</a>
 (412329008), <a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C0004475&amp;fLockTerm=Azacitidine">Azacitidine</a>
 (88551000), <a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C0049065&amp;fLockTerm=Decitabine">Decitabine</a>
 (420517007), <a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C0049065&amp;fLockTerm=Decitabine">Decitabine</a>
 (420759005), <a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C0033325&amp;fLockTerm=Determination+of+prognosis">Determination of prognosis</a>
 (20481000), <a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C3463824&amp;fLockTerm=Myelodysplastic+syndrome">Myelodysplastic syndrome</a>
 (109995007), <a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C3463824&amp;fLockTerm=Myelodysplastic+syndrome">Myelodysplastic syndrome</a>
 (128623006)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
    </div>
        <!-- /.content-tab-panel -->
        <!-- /.content-tab-panel -->
        <!-- TOOLBAR -->
        <div class="content-toolbar">

            <!-- Primary -->
            <ul class="tools primary-tools">
                <li class="dropdown tool sections">
                    <a href="#" class="tool-button">Sections</a>
                    <div class="dropdown-panel">
                            <ul class="section-links">
                                    <li><a href="#563" class="section-mark">Measure Domain</a></li>
                                    <li><a href="#566" class="section-mark">Brief Abstract</a></li>
                                    <li><a href="#573" class="section-mark">Evidence Supporting the Measure</a></li>
                                    <li><a href="#580" class="section-mark">State of Use of the Measure</a></li>
                                    <li><a href="#583" class="section-mark">Application of the Measure in its Current Use</a></li>
                                    <li><a href="#660" class="section-mark">National Strategy for Quality Improvement in Health Care</a></li>
                                    <li><a href="#590" class="section-mark">Institute of Medicine (IOM) National Health Care Quality Report Categories</a></li>
                                    <li><a href="#593" class="section-mark">Data Collection for the Measure</a></li>
                                    <li><a href="#605" class="section-mark">Computation of the Measure</a></li>
                                    <li><a href="#615" class="section-mark">Identifying Information</a></li>
                                    <li><a href="#99999" class="section-mark">Disclaimer</a></li>
                            </ul>    
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
            </ul>

            <!-- Other -->
            <ul class="tools other-tools">
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Download</a>

                    <div class="dropdown-panel">
                        <ul>
                            <li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/summaries/downloadcontent/nqmc-11022?contentType=pdf" class="pdf">.PDF 92.1 kb</a></li>
                            <li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/summaries/downloadcontent/nqmc-11022?contentType=word" class="word">Word Document 275.1 kb</a></li>
                            <li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/summaries/downloadcontent/nqmc-11022?contentType=xml" class="xml">.XML 26.8 kb</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Share</a>
                    <div class="dropdown-panel">
                        <ul class="toolbar-social">
                            <li><a target="_blank" href="https://web.archive.org/web/20180621173252/https://www.facebook.com/sharer/sharer.php?u=https://www.qualitymeasures.ahrq.gov/summaries/summary/50683/myelodysplastic-syndromes-mds-percentage-of-higherrisk-mds-patients-receiving-azacitidine-or-decitabine" class="facebook">Facebook</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180621173252/https://twitter.com/share?text=&amp;url=https://www.qualitymeasures.ahrq.gov/summaries/summary/50683/myelodysplastic-syndromes-mds-percentage-of-higherrisk-mds-patients-receiving-azacitidine-or-decitabine" class="twitter">Twitter</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180621173252/https://www.linkedin.com/shareArticle?mini=true&amp;url=https://www.qualitymeasures.ahrq.gov/summaries/summary/50683/myelodysplastic-syndromes-mds-percentage-of-higherrisk-mds-patients-receiving-azacitidine-or-decitabine&amp;title=&amp;summary=&amp;source=" class="linkedin">Linkedin</a></li>
                            <li><a href="https://web.archive.org/web/20180621173252/mailto:/?Subject=AHRQ: Myelodysplastic syndromes (MDS): percentage of higher-risk MDS patients receiving azacitidine or decitabine.&amp;body=https://www.qualitymeasures.ahrq.gov/summaries/summary/50683/myelodysplastic-syndromes-mds-percentage-of-higherrisk-mds-patients-receiving-azacitidine-or-decitabine" class="email">Email</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Cite</a>
                    <div class="dropdown-panel citation">
                        <p class="text-label"><label for="citation">Citation: </label></p>
                        <textarea id="citation">National Quality Measures Clearinghouse (NQMC). Measure summary: Myelodysplastic syndromes (MDS): percentage of higher-risk MDS patients receiving azacitidine or decitabine. In: National Quality Measures Clearinghouse (NQMC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2017 Feb 01. [cited 2018 Jun 21]. Available: https://www.qualitymeasures.ahrq.gov</textarea>                        
                        <p class="text-label">Download citation file: </p>
                        <ul>
                            <li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/summaries/citedownload/50683?format=ris">RIS (Zotero)</a></li>
                            <li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/summaries/citedownload/50683?format=enw">EndNote</a></li>
                            <li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/summaries/citedownload/50683?format=bibtex">BibTex</a></li>
                            <li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/summaries/citedownload/50683?format=txt">Medlars</a></li>
                            <li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/summaries/citedownload/50683?format=ris">ProCite</a></li>
                            <li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/summaries/citedownload/50683">RefWorks</a></li>
                            <li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/summaries/citedownload/50683?format=ris">Reference Manager</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                                
                <li class="tool">
                        <a href="#" id="50683" data-alert="SignInLanding" class="tool-button save-link">Save</a>
                </li>
            </ul>

            <!-- Accordion -->
            <ul class="tools accordion-controls">
                <li class="tool"><a href="#" class="expand-all is-disabled" aria-disabled="true"><span class="screen-reader-text">Expand All</span></a></li>
                <li class="tool"><a href="#" class="collapse-all" aria-disabled="false"><span class="screen-reader-text">Collapse All</span></a></li>
            </ul>
        </div>
        <!-- /.toolbar -->


		<!-- ARTICLE -->
		<div class="article" id="article">
			




    <!-- ACCORDION -->
    <div class="accordion-container" role="tablist" multiselectable="true">
                <h2 id="563" class="accordion-title section-563 is-active" role="tab" aria-expanded="true"><a href="#">Measure Domain</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Primary Measure Domain</a></h3>
                    <p>Clinical Quality Measures: Process</p>
                        <h3><a href="#">Secondary Measure Domain</a></h3>
                    <p>Does not apply to this measure</p>

            </div>
                <h2 id="566" class="accordion-title section-566 is-active" role="tab" aria-expanded="true"><a href="#">Brief Abstract</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Description</a></h3>
                    <p><div class="content_para"><p>This measure is used to assess the percentage of higher-risk (intermediate-2, or high-risk using International Prognostic Scoring System [IPSS], very high-risk using IPSS-R, and/or with excess blasts, or high- or very high-risk using World Health Organization-based Prognostic Scoring System [WPSS]) myelodysplastic syndromes (MDS) patients greater than 18 years old receiving azacitidine or decitabine.</p></div></p>
                        <h3><a href="#">Rationale</a></h3>
                    <p><div class="content_para"><p><em>Statement from the Myelodysplastic Syndromes (MDS) Task Force</em>:<br/>
Recently revised National Comprehensive Cancer Network (NCCN) guidelines for MDS (2015) recommend the use of azacitidine or decitabine within the algorithm for the treatment of higher-risk MDS patients. The definition of higher risk patient was expanded to include World Health Organization-based Prognostic Scoring System (WPSS) High and Very High in 2014.</p>
<p><em>Excerpts (verbatim) from guidelines</em>:<br/>
[Conventional d]rug treatments for patients with high-risk myelodysplastic syndromes provide no survival advantage. In this trial, we aimed to assess the effect of azacitidine on overall survival compared with the three commonest conventional care regimens&hellip; Treatment with azacitidine increases overall survival in patients with higher-risk myelodysplastic syndromes relative to conventional care (Fenaux et al., 2009).</p>
<p>[In a study to compare low-dose decitabine to best supportive care (BSC) in higher-risk patients with myelodysplastic syndrome (MDS) age 60 years or older and ineligible for intensive chemotherapy&hellip;] Decitabine administered in 6-week cycles is active in older patients with higher-risk MDS, resulting in improvements of OS [overall survival] and AMLFS [acute myeloid leukemia-free survival] (nonsignificant), of PFS [progression-free survival] and AML transformation (significant), and of QOL [quality of life] (L&uuml;bbert et al., 2011).</p></div></p>
                        <h3><a href="#">Evidence for Rationale</a></h3>
                    <p><table><tr><td>American Society of Hematology (ASH). Myelodysplastic syndromes (MDS) measure set: measure specifications. Washington (DC): American Society of Hematology (ASH); 2017 Feb. 14 p. </td></tr></table></p>
                    <p><table><tr><td>Fenaux P, Mufti GJ, Hellstrom-Lindberg E, Santini V, Finelli C, Giagounidis A, Schoch R, Gattermann N, Sanz G, List A, Gore SD, Seymour JF, Bennett JM, Byrd J, Backstrom J, Zimmerman L, McKenzie D, Beach C, Silverman LR, International Vidaza High-Risk MDS Survival Study Group. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. Lancet Oncol. 2009 Mar;10(3):223-32. <a href="https://web.archive.org/web/20180621173252/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=19230772" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180621173252im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Lübbert M, Suciu S, Baila L, Rüter BH, Platzbecker U, Giagounidis A, Selleslag D, Labar B, Germing U, Salih HR, Beeldens F, Muus P, Pflüger KH, Coens C, Hagemeijer A, Eckart Schaefer H, Ganser A, Aul C, de Witte T, Wijermans PW. Low-dose decitabine versus best supportive care in elderly patients with intermediate- or high-risk myelodysplastic syndrome (MDS) ineligible for intensive chemotherapy: final results of the randomized phase III study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group. J Clin Oncol. 2011 May 20;29(15):1987-96. <a href="https://web.archive.org/web/20180621173252/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=21483003" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180621173252im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology: myelodysplastic syndromes. V1.2016. Fort Washington (PA): National Comprehensive Cancer Network (NCCN); 2015 May 28. </td></tr></table></p>
                        <h3><a href="#">Primary Health Components</a></h3>
                    <p><div class="content_para"><p>Higher-risk myelodysplastic syndromes (MDS); International Prognostic Scoring System (IPSS, IPSS-R); World Health Organization-Based Prognostic Scoring System (WPSS); azacitidine; decitabine</p></div></p>
                        <h3><a href="#">Denominator Description</a></h3>
                    <p><div class="content_para"><p>The number of myelodysplastic syndromes (MDS) patients in your selection who are higher-risk (intermediate-2, or high-risk using International Prognostic Scoring System [IPSS], very high-risk using IPSS-R, and/or with excess blasts, or high- or very high-risk using World Health Organization-based Prognostic Scoring System [WPSS]) </p>
<p>See the related "Denominator Inclusions/Exclusions" field.</p></div></p>
                        <h3><a href="#">Numerator Description</a></h3>
                    <p><div class="content_para"><p>The number of myelodysplastic syndromes (MDS) patients in your selection who are</p>
<ul style="list-style-type: disc;">
    <li>Higher-risk (intermediate-2, or high-risk using International Prognostic Scoring System [IPSS], very high-risk using IPSS-R, and/or with excess blasts, or high- or very high-risk using World Health Organization-based Prognostic Scoring System [WPSS])
    <p>AND </p>
    </li>
    <li>Receiving azacitidine or decitabine </li>
</ul>
<p>See the related "Numerator Inclusions/Exclusions" field.</p></div></p>

            </div>
                <h2 id="573" class="accordion-title section-573 is-active" role="tab" aria-expanded="true"><a href="#">Evidence Supporting the Measure</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Type of Evidence Supporting the Criterion of Quality for the Measure</a></h3>
                    <p><ul><li>A clinical practice guideline or other peer-reviewed synthesis of the clinical research evidence</li><li>One or more research studies published in a National Library of Medicine (NLM) indexed, peer-reviewed journal</li></ul></p>
                        <h3><a href="#">Additional Information Supporting Need for the Measure</a></h3>
                    <p><div class="content_para"><p><em>Evidence of gap</em>:<br/>
The use of azacitidine or decitabine for the treatment of higher-risk myelodysplastic syndromes (MDS) is a recent addition to the National Comprehensive Cancer Network (NCCN) guidelines. For this reason, we believe there is a gap in use of these therapeutic options. Since 2013, performance for this measure was 79% for 203 patients.</p></div></p>
                        <h3><a href="#">Evidence for Additional Information Supporting Need for the Measure</a></h3>
                    <p><table><tr><td>American Society of Hematology (ASH). Myelodysplastic syndromes (MDS) measure set: measure specifications. Washington (DC): American Society of Hematology (ASH); 2017 Feb. 14 p. </td></tr></table></p>
                        <h3><a href="#">Extent of Measure Testing</a></h3>
                    <p><div class="content_para"><p>The myelodysplastic syndromes (MDS) measure set was developed by the American Society of Hematology (ASH) using a rigorous methodology (adapted from the American Medical Association [AMA]-convened Physician Consortium for Performance Improvement [PCPI]) and has been field tested. The MDS measure set was accepted by American Board of Internal Medicine (ABIM) for use with practice improvement modules meeting Part 4 of Maintenance of Certification Requirements in 2006.</p></div></p>
                        <h3><a href="#">Evidence for Extent of Measure Testing</a></h3>
                    <p><table><tr><td>Frechette S. (Principal, Northfield Associates, LLC, Warren, VT). Personal communication. 2014 Dec 10. &nbsp;1 p. </td></tr></table></p>

            </div>
                <h2 id="580" class="accordion-title section-580 is-active" role="tab" aria-expanded="true"><a href="#">State of Use of the Measure</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">State of Use</a></h3>
                    <p>Current routine use</p>
                        <h3><a href="#">Current Use</a></h3>
                    <p>Certification</p>
                    <p>Internal quality improvement</p>
                    <p>Professional certification</p>

            </div>
                <h2 id="583" class="accordion-title section-583 is-active" role="tab" aria-expanded="true"><a href="#">Application of the Measure in its Current Use</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Measurement Setting</a></h3>
                    <p>Ambulatory/Office-based Care</p>
                        <h3><a href="#">Professionals Involved in Delivery of Health Services</a></h3>
                    <p>Physicians</p>
                        <h3><a href="#">Least Aggregated Level of Services Delivery Addressed</a></h3>
                    <p>Individual Clinicians or Public Health Professionals</p>
                        <h3><a href="#">Statement of Acceptable Minimum Sample Size</a></h3>
                    <p>Specified</p>
                        <h3><a href="#">Target Population Age</a></h3>
                    <p><div class="content_para"><p>Age greater than 18 years</p></div></p>
                        <h3><a href="#">Target Population Gender</a></h3>
                    <p>Either male or female</p>

            </div>
                <h2 id="660" class="accordion-title section-660 is-active" role="tab" aria-expanded="true"><a href="#">National Strategy for Quality Improvement in Health Care</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">National Quality Strategy Aim</a></h3>
                    <p>Better Care</p>
                        <h3><a href="#">National Quality Strategy Priority</a></h3>
                    <p>Prevention and Treatment of Leading Causes of Mortality</p>

            </div>
                <h2 id="590" class="accordion-title section-590 is-active" role="tab" aria-expanded="true"><a href="#">Institute of Medicine (IOM) National Health Care Quality Report Categories</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">IOM Care Need</a></h3>
                    <p>Living with Illness</p>
                        <h3><a href="#">IOM Domain</a></h3>
                    <p>Effectiveness</p>

            </div>
                <h2 id="593" class="accordion-title section-593 is-active" role="tab" aria-expanded="true"><a href="#">Data Collection for the Measure</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Case Finding Period</a></h3>
                    <p><div class="content_para"><p>Unspecified</p></div></p>
                        <h3><a href="#">Denominator Sampling Frame</a></h3>
                    <p>Patients associated with provider</p>
                        <h3><a href="#">Denominator (Index) Event or Characteristic</a></h3>
                    <p>Clinical Condition</p>
                    <p>Diagnostic Evaluation</p>
                    <p>Encounter</p>
                    <p>Patient/Individual (Consumer) Characteristic</p>
                        <h3><a href="#">Denominator Time Window</a></h3>
                    <p>Does not apply to this measure</p>
                        <h3><a href="#">Denominator Inclusions/Exclusions</a></h3>
                    <p><div class="content_para"><p><strong>Inclusions </strong><br/>
The number of myelodysplastic syndromes (MDS) patients in your selection who are higher-risk (intermediate-2, or high-risk using International Prognostic Scoring System [IPSS], very high-risk using IPSS-R, and/or with excess blasts, or high- or very high-risk using World Health Organization-based Prognostic Scoring System [WPSS])</p>
<p>Patients can be included in the chart abstraction if:</p>
<ul style="list-style-type: disc;">
    <li>They have been seen by the practice within the past 18 months </li>
    <li>Management decisions regarding care are made primarily by providers in the practice </li>
    <li>They are greater than 18 years old (or the age at which your institution refers to adult hematologists) </li>
</ul>
<p class="Note"><strong>Note</strong>: Refer to the original measure documentation for a list of International Classification of Diseases, Tenth Revision (ICD-10) codes used in MDS patient selection. </p>
<p><strong>Exclusions</strong></p>
<ul style="list-style-type: disc;">
    <li>Patient with successful hematopoietic stem cell transplant </li>
    <li>Patient refused treatment </li>
</ul></div></p>
                        <h3><a href="#">Exclusions/Exceptions</a></h3>
                    <p>Medical factors addressed</p>
                    <p>Patient factors addressed</p>
                        <h3><a href="#">Numerator Inclusions/Exclusions</a></h3>
                    <p><div class="content_para"><p><strong>Inclusions</strong><br/>
The number of myelodysplastic syndromes (MDS) patients in your selection who are </p>
<ul style="list-style-type: disc;">
    <li>Higher-risk (intermediate-2, or high-risk using International Prognostic Scoring System [IPSS], very high-risk using IPSS-R, and/or with excess blasts, or high- or very high-risk using World Health Organization-Based Prognostic Scoring System [WPSS])
    <p>AND </p>
    </li>
    <li>Receiving azacitidine or decitabine </li>
</ul>
<p class="Note"><strong>Note</strong>: Receiving azacitidine or decitabine means you prescribed or confirmed that the patient was prescribed azacitidine or decitabine. Refer to the original measure documentation for a list of International Classification of Diseases, Tenth Revision (ICD-10) codes used in MDS patient selection and a list of Healthcare Common Procedure Coding System (HCPCS) codes for azacitidine or decitabine.</p>
<p><strong>Exclusions</strong></p>
<ul style="list-style-type: disc;">
    <li>Patient with successful hematopoietic stem cell transplant </li>
    <li>Patient refused treatment </li>
</ul></div></p>
                        <h3><a href="#">Numerator Search Strategy</a></h3>
                    <p>Fixed time period or point in time</p>
                        <h3><a href="#">Data Source</a></h3>
                    <p>Administrative clinical data</p>
                    <p>Paper medical record</p>
                        <h3><a href="#">Type of Health State</a></h3>
                    <p>Does not apply to this measure</p>
                        <h3><a href="#">Instruments Used and/or Associated with the Measure</a></h3>
                    <p><div class="content_para"><p>Unspecified</p></div></p>

            </div>
                <h2 id="605" class="accordion-title section-605 is-active" role="tab" aria-expanded="true"><a href="#">Computation of the Measure</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Measure Specifies Disaggregation</a></h3>
                    <p>Does not apply to this measure</p>
                        <h3><a href="#">Scoring</a></h3>
                    <p>Rate/Proportion</p>
                        <h3><a href="#">Interpretation of Score</a></h3>
                    <p>Desired value is a higher score</p>
                        <h3><a href="#">Allowance for Patient or Population Factors</a></h3>
                    <p>Unspecified</p>
                        <h3><a href="#">Standard of Comparison</a></h3>
                    <p>Internal time comparison</p>

            </div>
                <h2 id="615" class="accordion-title section-615 is-active" role="tab" aria-expanded="true"><a href="#">Identifying Information</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Original Title</a></h3>
                    <p><div class="content_para"><p>Measure 5: Higher-risk (intermediate-2, or high-risk using IPSS, very high-risk using IPSS-R, and/or with excess blasts, or high- or very high-risk using WPSS) MDS patient receiving azacitidine or decitabine.</p></div></p>
                        <h3><a href="#">Measure Collection Name</a></h3>
                    <p>Myelodysplastic Syndromes Measure Set</p>
                        <h3><a href="#">Submitter</a></h3>
                    <p>American Society of Hematology - Medical Specialty Society</p>
                        <h3><a href="#">Developer</a></h3>
                    <p>American Society of Hematology - Medical Specialty Society</p>
                        <h3><a href="#">Funding Source(s)</a></h3>
                    <p><div class="content_para"><p>The American Society of Hematology</p></div></p>
                        <h3><a href="#">Composition of the Group that Developed the Measure</a></h3>
                    <p><div class="content_para"><p>The American Society of Hematology (ASH) Myelodysplastic Syndromes (MDS) Task Force:</p>
<ul style="list-style-type: disc;">
    <li>Lawrence A. Solberg, Jr., MD, PhD (<em>Chair</em>) </li>
    <li>Mikkael Sekeres, MD, MS </li>
    <li>Timothy Miley, MD </li>
    <li>Kenneth R. Adler, MD </li>
    <li>Steven Allen, MD </li>
    <li>David P. Steensma, Jr., MD, PhD </li>
    <li>Karen Kayoumi (ASH) </li>
    <li>Charles Clayton (ASH) </li>
    <li>Suzanne Leous (ASH) </li>
    <li>Sue Frechette, RN, MBA (Northfield Associates LLC) </li>
    <li>Debra Reis (Healthmonix) </li>
    <li>Lauren Patrick (Healthmonix) </li>
</ul></div></p>
                        <h3><a href="#">Financial Disclosures/Other Potential Conflicts of Interest</a></h3>
                    <p><div class="content_para"><p>Unspecified</p></div></p>
                        <h3><a href="#">Adaptation</a></h3>
                    <p><div class="content_para"><p>This measure was not adapted from another source.</p></div></p>
                        <h3><a href="#">Date of Most Current Version in NQMC</a></h3>
                    <p>2017 Feb</p>
                        <h3><a href="#">Measure Maintenance</a></h3>
                    <p><div class="content_para"><p>American Society of Hematology (ASH) reviews/updates measures annually</p></div></p>
                        <h3><a href="#">Date of Next Anticipated Revision</a></h3>
                    <p><div class="content_para"><p>Unspecified</p></div></p>
                        <h3><a href="#">Measure Status</a></h3>
                    <p><div class="content_para"><p>This is the current release of the measure.</p>
<p>This measure updates a previous version: American Society of Hematology (ASH). Myelodysplastic syndromes (MDS) measure set: measure specifications. Washington (DC): American Society of Hematology (ASH); 2015 Dec. 16 p.</p></div></p>
                        <h3><a href="#">Source(s)</a></h3>
                    <p><table><tr><td>American Society of Hematology (ASH). Myelodysplastic syndromes (MDS) measure set: measure specifications. Washington (DC): American Society of Hematology (ASH); 2017 Feb. 14 p. </td></tr></table></p>
                        <h3><a href="#">Measure Availability</a></h3>
                    <p><div class="content_para"><p>Source not available electronically.</p>
<p>For more information, contact the American Society of Hematology (ASH) at 2021 L Street NW, Suite 900, Washington, DC 20036; Phone: 202-776-0544; Fax: 202-776-0545; Web site: <a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/Home/Disclaimer?id=50683&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.hematology.org" title="ASH Web site">www.hematology.org</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180621173252im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/>.</p></div></p>
                        <h3><a href="#">NQMC Status</a></h3>
                    <p><div class="content_para"><p>This NQMC summary was completed by ECRI Institute on July 20, 2015. The information was verified by the measure developer on August 27, 2015. </p>
<p>This NQMC summary was updated by ECRI Institute on April 18, 2016. The information was verified by the measure developer on May 24, 2016. </p>
<p>This NQMC summary was updated again by ECRI Institute on March 21, 2017. The information was verified by the measure developer on May 3, 2017.</p></div></p>
                        <h3><a href="#">Copyright Statement</a></h3>
                    <p><div class="content_para"><p>This NQMC summary is based on the original measure, which is subject to the measure developer's copyright restrictions.</p>
<p>For more information, contact Robert M. Plovnick, MD, MS, Director of Quality Improvement Programs at American Society of Hematology 2021 L Street NW, Suite 900 Washington, DC 20036.</p></div></p>

            </div>
                <h2 id="99999" class="accordion-title section-99999 is-active" role="tab" aria-expanded="true"><a href="#">Disclaimer</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">NQMC Disclaimer</a></h3>
                    <p><p>The National Quality Measures Clearinghouse™ (NQMC) does not develop, produce, approve, or endorse the measures represented on this site.</p> 
<p>All measures summarized by NQMC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public and private organizations, other government agencies, health care organizations or plans, individuals, and similar entities.</p> 
<p>Measures represented on the NQMC Web site are submitted by measure developers, and are screened solely to determine that they meet the <a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/help-and-about/summaries/inclusion-criteria">NQMC Inclusion Criteria</a>.</p> 
<p>NQMC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or its reliability and/or validity of the quality measures and related materials represented on this site. Moreover, the views and opinions of developers or authors of measures represented on this site do not necessarily state or reflect those of NQMC, AHRQ, or its contractor, ECRI Institute, and inclusion or hosting of measures in NQMC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding measure content are directed to contact the measure developer.</p></p>

            </div>

    </div>
    <!-- /.accordion-container -->

<!-- ASIDE -->
<!-- FOOTER -->






		</div><!-- /.article -->

	</div><!-- /.content -->

	
			<div class="aside">
				

    <!-- About NGC -->
    <div class="info-block">
            <h3 class="info prefix-icon large-icon">About NQMC Measure Summaries</h3>
            <p>NQMC provides structured summaries containing information about measures and their development.</p>
            <ul>
                <li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/help-and-about/summaries/domain-framework" class="internal-link">Domain Framework</a></li>
                <li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/help-and-about/summaries/inclusion-criteria" class="internal-link">Inclusion Criteria</a></li>
                <li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/help-and-about/summaries/template-of-measure-attributes" class="internal-link">Template of Measure Attributes</a></li>
                <li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/help-and-about/summaries/classification-scheme" class="internal-link">Classification Scheme</a></li>
            </ul>
            <p><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/help-and-about/summaries/faqs" class="help-button">Measure Summary FAQs</a></p>

    </div>
    <!-- /info-block -->

    <!-- Guideline Synthesis -->

    <!-- HHS Block -->

    <!-- Related Content -->


    <hr>

    <!-- New on NGC -->
    <div class="subscribe-header">
        <h3 class="subscribe-title">New on NQMC</h3>
        <ul class="subscribe-links">
            <li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/subscribe" class="newsletter"><span class="subscribe-links-label">Get Email Alerts</span></a></li>
            <li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/rssFiles/nqmc_newthisweek.xml" class="rss"><span class="subscribe-links-label">RSS Feed</span></a></li>
        </ul>
    </div>
    <!-- /.subscribe-header -->
        <h5 class="prefix-icon measure news-list-category-label">Measure Summaries</h5>
    
    <a class="block-link" href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/new-this-week/index">
        <h3>New This Week </h3>
        <p>View more and sign up for our Newsletter</p>
    </a>
    <!-- Adobe Reader -->
    <p><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/disclaimer?id=50683&amp;contentType=summary&amp;redirect=http%3A%2F%2Fget.adobe.com%2Freader%2F" class="external-link">Get Adobe Reader</a></p>

			</div><!-- /.aside -->
		</div><!-- /.aside-container -->

	<!-- BACK TO TOP -->
	
	
	



    <!-- COMMENTS -->
    

</div><!-- /.main -->

	</main>

	<!-- FOOTER -->
	<div class="footer" id="footer">

		<div class="footer-grid-container">
			<!-- Header -->
			<div class="footer-header">
				<a href="#" class="footer-logo">
			 		<picture>
					  	<source type="image/svg+xml" srcset="/web/20180621173252im_/https://www.qualitymeasures.ahrq.gov/UI/images/logo_NQMC_footer.svg">
					  	<img src="/web/20180621173252im_/https://www.qualitymeasures.ahrq.gov/UI/images/logo_NQMC_footer.png" alt="NQMC">
					</picture>
				</a>
			</div><!-- /.footer-header -->

			<!-- Content -->
			<div class="footer-content">
				<div class="footer-nav">
					<ul class="level-1">
						<li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/">Home</a></li>
		                <li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/new-this-week/index">New This Week</a></li>
						<li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/browse/organization" class="parent-link">Measure Summaries</a></li>
						<li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/expert">Expert Commentaries</a></li>
		                <li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/matrix">Matrix Tool</a></li>
						<li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/summaries/submit">Submit Measures</a></li>
						<li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/help-and-about">Help &amp;&nbsp;About</a></li>
					</ul>
					<ul class="level-2">
						<li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/contact-us">Contact Us</a></li>
						<li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/rss">RSS</a></li>
					    <li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/site-map">Site Map</a></li>
                        <li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/browse/related">Related NGC Guidelines</a></li>
                        <li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/help-and-about/about/editorial-board">Editorial Board</a></li>
                        <li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/help-and-about/general/web-site-credits">Web Site Credits</a></li>
                        <li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/help-and-about/general/disclaimer">Disclaimer</a></li>
						<li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/help-and-about/general/privacy">Privacy Policy</a></li>
                        <li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/help-and-about/technical/accessibility">Accessibility</a></li>	
                        <li><a href="/web/20180621173252/https://www.qualitymeasures.ahrq.gov/help-and-about/technical/for-web-developers">For Web Developers</a></li>
					</ul>
				</div><!-- /.footer-nav -->
			</div><!-- /.footer-content -->

			<!-- Aside -->
			<div class="footer-aside">
				<h5 class="footer-partner-link-header">Visit our partner sites</h5>
				<ul class="footer-partner-links">
					<li><!-- NGC footer link -->
						<a href="https://web.archive.org/web/20180621173252/https://www.guideline.gov/" target="_blank" class="partner-button ngc">
							<span class="partner-logo">
								<picture>
								    <source type="image/svg+xml" srcset="/web/20180621173252im_/https://www.qualitymeasures.ahrq.gov/UI/images/logo_footerlink_ngc.svg">
									<img src="/web/20180621173252im_/https://www.qualitymeasures.ahrq.gov/UI/images/logo_footerlink_ngc.png" alt="National Guidelines Clearinghouse"/>
								</picture>
							</span>
						</a>
					</li><!--/NGC footer link -->
					<li><!-- HHS footer link --> 
						<a href="https://web.archive.org/web/20180621173252/https://www.qualitymeasures.ahrq.gov/hhs/index.aspx" target="_blank" class="partner-button hhs">
							<span class="partner-logo">
								<picture>
								    <source type="image/svg+xml" srcset="/web/20180621173252im_/https://www.qualitymeasures.ahrq.gov/UI/images/logo_footerlink_hmis.svg">
								    <img src="/web/20180621173252im_/https://www.qualitymeasures.ahrq.gov/UI/images/logo_footerlink_hmis.png" alt="HHS Measures Inventory"/>
								</picture>
							</span>
						</a>
					</li><!--/HHS footer link -->
				</ul>
			</div><!-- /.footer-aside -->

		</div><!-- /.footer-grid-container -->

	</div><!-- /.footer -->

	
	<!-- AHRQ FOOTER -->
	<div id="ahrq-footer">

		<!-- FIRST -->
		<div class="ahrq-first-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<p><a href="https://web.archive.org/web/20180621173252/http://www.ahrq.gov/index.html" class="ahrq-footer-logo" target="_blank">AHRQ</a></p>
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180621173252/http://www.ahrq.gov/policy/electronic/accessibility/index.html" target="_blank">Accessibility</a></li>
						<li><a href="https://web.archive.org/web/20180621173252/http://www.ahrq.gov/policy/electronic/disclaimers/index.html" target="_blank">Disclaimers</a></li>
						<li><a href="https://web.archive.org/web/20180621173252/http://www.ahrq.gov/policy/eeo/index.html" target="_blank">EEO</a></li>
						<li><a href="https://web.archive.org/web/20180621173252/http://www.ahrq.gov/policy/foia/index.html" target="_blank">FOIA</a></li>
						<li><a href="https://web.archive.org/web/20180621173252/http://www.hhs.gov/web/governance/digital-strategy/index.html" target="_blank">HHS Digital Strategy</a></li>
						<li><a href="https://web.archive.org/web/20180621173252/http://oig.hhs.gov/" target="_blank">Inspector General</a></li>
						<li><a href="https://web.archive.org/web/20180621173252/http://www.ahrq.gov/policy/electronic/plain-writing/index.html" target="_blank">Plain Writing Act</a></li>
						<li><a href="https://web.archive.org/web/20180621173252/http://www.ahrq.gov/policy/electronic/privacy/index.html" target="_blank">Privacy Policy</a></li>
						<li><a href="https://web.archive.org/web/20180621173252/http://www.ahrq.gov/policy/electronic/about/policyix.html" target="_blank">Electronic Policies</a></li>
						<li><a href="https://web.archive.org/web/20180621173252/http://www.hhs.gov/plugins.html" target="_blank">Viewers &amp; Players</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<h3>Get Social</h3>
					<ul class="ahrq-social">
						<li><a href="https://web.archive.org/web/20180621173252/http://www.facebook.com/" target="_blank" class="facebook"><span class="screen-reader-text">Facebook</span></a></li>
						<li><a href="https://web.archive.org/web/20180621173252/http://www.twitter.com/" target="_blank" class="twitter"><span class="screen-reader-text">Twitter</span></a></li>
						<li><a href="https://web.archive.org/web/20180621173252/http://www.linkedin.com/" target="_blank" class="linkedin"><span class="screen-reader-text">LinkedIn</span></a></li>
						<li><a href="https://web.archive.org/web/20180621173252/http://www.youtube.com/" target="_blank" class="youtube"><span class="screen-reader-text">YouTube</span></a></li>
					</ul>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.first-footer -->

		<!-- SECOND -->
		<div class="ahrq-second-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<ul>
						<li><a href="https://web.archive.org/web/20180621173252/http://www.ahrq.gov/index.html" target="_blank" class="ahrq-footer-home-link"><span class="screen-reader-text">AHRQ Home</span></a></li>
						<li><a href="https://web.archive.org/web/20180621173252/http://www.ahrq.gov/cpi/about/index.html" target="_blank">About Us</a></li>
						<li><a href="https://web.archive.org/web/20180621173252/http://www.ahrq.gov/cpi/about/careers/index.html" target="_blank">Careers</a></li>
						<li><a href="https://web.archive.org/web/20180621173252/http://www.ahrq.gov/contact/index.html" target="_blank">Contact Us</a></li>
						<li><a href="https://web.archive.org/web/20180621173252/http://www.ahrq.gov/Sitemap.html" target="_blank">Sitemap</a></li>
						<li><a href="https://web.archive.org/web/20180621173252/https://info.ahrq.gov/" target="_blank">FAQ</a></li>
					</ul>	
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180621173252/http://www.ahrq.gov/health-care-information/index.html" target="_blank">Health Care Information</a></li>
						<li><a href="https://web.archive.org/web/20180621173252/http://www.ahrq.gov/patients-consumers/index.html" target="_blank">For Patients &amp; Consumers</a></li>
						<li><a href="https://web.archive.org/web/20180621173252/http://www.ahrq.gov/professionals/index.html" target="_blank">For Professionals</a></li>
						<li><a href="https://web.archive.org/web/20180621173252/http://www.ahrq.gov/policymakers/index.html" target="_blank">For Policymakers</a></li>
						<li><a href="https://web.archive.org/web/20180621173252/http://www.ahrq.gov/research/index.html" target="_blank">Research Tools &amp; Data</a></li>
						<li><a href="https://web.archive.org/web/20180621173252/http://www.ahrq.gov/funding/index.html" target="_blank">Funding &amp; Grants</a></li>
						<li><a href="https://web.archive.org/web/20180621173252/http://www.ahrq.gov/cpi/index.html" target="_blank">Offices, Centers &amp; Programs</a></li>
						<li><a href="https://web.archive.org/web/20180621173252/http://www.ahrq.gov/news/index.html" target="_blank">News &amp; Events</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<ul>
						<li><a href="https://web.archive.org/web/20180621173252/http://www.hhs.gov/" target="_blank">U.S. Department of Health &amp; Human Services</a></li>
						<li><a href="https://web.archive.org/web/20180621173252/http://www.whitehouse.gov/" target="_blank">The White House</a></li>
						<li><a href="https://web.archive.org/web/20180621173252/http://www.usa.gov/" target="_blank">USA.gov: The U.S. Government's Official Web Portal   </a></li>
					</ul>
					<p class="ahrq-address">
						<strong>Agency for Healthcare Research&nbsp;and&nbsp;Quality</strong>
					    <br/>5600 Fishers Lane
					    <br/>Rockville, MD 20857
					    <br/><strong>Telephone:</strong> (301) 427-1364
					</p>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.second-footer -->
	</div><!-- /#ahrq-footer -->


	
	<!-- SCRIPTS -->
	
<script src="//web.archive.org/web/20180621173252js_/https://ajax.googleapis.com/ajax/libs/jquery/1.6.3/jquery.min.js" type="text/javascript"></script>
<script type="text/javascript">
if(!window.jQuery){
document.write('<script src="/cassette.axd/script/cdd67f922f9d413eaccb759182297335f87c3ff7/UI/js/jquery.js" type="text/javascript"><\/script>');
}
</script>
<script src="/web/20180621173252js_/https://www.qualitymeasures.ahrq.gov/cassette.axd/script/595952c286b7fd52f0737b6f62085709be93156a/bodyJS" type="text/javascript"></script>

    
</body>
</html>
<!--
     FILE ARCHIVED ON 17:32:52 Jun 21, 2018 AND RETRIEVED FROM THE
     INTERNET ARCHIVE ON 19:40:12 Jul 15, 2018.
     JAVASCRIPT APPENDED BY WAYBACK MACHINE, COPYRIGHT INTERNET ARCHIVE.

     ALL OTHER CONTENT MAY ALSO BE PROTECTED BY COPYRIGHT (17 U.S.C.
     SECTION 108(a)(3)).
-->
<!--
playback timings (ms):
  LoadShardBlock: 72.494 (3)
  esindex: 0.012
  captures_list: 189.677
  CDXLines.iter: 19.606 (3)
  PetaboxLoader3.datanode: 32.376 (4)
  exclusion.robots: 0.194
  exclusion.robots.policy: 0.176
  RedisCDXSource: 93.544
  PetaboxLoader3.resolve: 119.877 (2)
  load_resource: 98.089
-->